Review: taking Reglan and Ranitidine together


Summary

Drug interactions are reported among people who take Reglan and Ranitidine together. This review analyzes the effectiveness and drug interactions between Reglan and Ranitidine. It is created by eHealthMe based on reports of 3,538 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Reglan and Ranitidine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Reglan

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in nausea. (latest outcomes from Reglan 20,926 users)

Ranitidine

Ranitidine has active ingredients of ranitidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Ranitidine 29,313 users)

On Aug, 21, 2016

3,538 people who take Reglan, Ranitidine are studied.


Number of reports submitted per year:

Reglan and Ranitidine drug interactions.

Drug effectiveness over time:

Reglan:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Ranitidine:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Reglan:
  • female: 25.0% - (3 of 12 people)
  • male: 0.0% - (0 of 1 people)
Ranitidine:
  • female: 33.0% - (4 of 12 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Reglan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 16.0% - (1 of 6 people)
Ranitidine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 33.0% - (2 of 6 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • anxiety
  • pain
  • multi-organ failure
  • renal failure
  • sepsis
  • depression
  • renal failure acute
  • abdominal pain
  • injury
1 - 6 months:
  • dehydration
  • abdominal pain
  • tardive dyskinesia
  • nausea
  • pneumonia
  • vomiting
  • fatigue
  • pain
  • anaemia
  • extrapyramidal disorder
6 - 12 months:
  • anxiety
  • tardive dyskinesia
  • depression
  • electrocardiogram qt prolonged
  • nausea
  • hallucination, visual
  • arthralgia
  • hyperkalaemia
  • renal failure
  • fatigue
1 - 2 years:
  • tardive dyskinesia
  • extrapyramidal disorder
  • anxiety
  • depression
  • fall
  • dysphagia
  • speech disorder
  • tremor
  • akathisia
  • asthenia
2 - 5 years:
  • tardive dyskinesia
  • depression
  • anxiety
  • extrapyramidal disorder
  • pain
  • tremor
  • dyskinesia
  • mental disorder
  • nervous system disorder
  • activities of daily living impaired
5 - 10 years:
  • tardive dyskinesia
  • emotional disorder
  • extrapyramidal disorder
  • anxiety
  • pain
  • tremor
  • back pain
  • dyskinesia
  • arthralgia
  • fatigue
10+ years:
  • tardive dyskinesia
  • extrapyramidal disorder
  • emotional disorder
  • anxiety
  • dyskinesia
  • dysphagia
  • injury
  • pain
  • tremor
  • dry mouth
not specified:
  • nausea
  • vomiting
  • pain
  • anxiety
  • dyspnoea
  • depression
  • pyrexia
  • weight decreased
  • fatigue
  • asthenia

Most common drug interactions by gender *:

female:
  • nausea
  • vomiting
  • anxiety
  • depression
  • pain
  • dyspnoea
  • weight decreased
  • fatigue
  • pyrexia
  • fall
male:
  • nausea
  • pain
  • pneumonia
  • anxiety
  • dyspnoea
  • vomiting
  • depression
  • pyrexia
  • asthenia
  • fatigue

Most common drug interactions by age *:

0-1:
  • irritability
  • bronchiolitis
  • pyrexia
  • drug maladministration
  • sedation
  • cough
  • tardive dyskinesia
  • crying
  • insomnia
  • vomiting
2-9:
  • pyrexia
  • dehydration
  • vomiting
  • diarrhoea
  • haematemesis
  • neutropenia
  • weight decreased
  • heart rate increased
  • cough
  • eyelid ptosis
10-19:
  • nausea
  • pyrexia
  • pneumonia
  • cardiac arrest
  • cholecystitis chronic
  • febrile neutropenia
  • diarrhoea
  • caecitis
  • escherichia infection
  • abdominal pain upper
20-29:
  • pain
  • vomiting
  • nausea
  • cholecystitis chronic
  • dyspnoea
  • abdominal pain upper
  • deep vein thrombosis
  • dizziness
  • drug exposure during pregnancy
  • headache
30-39:
  • pain
  • convulsion
  • nausea
  • depression
  • gastrooesophageal reflux disease
  • vomiting
  • anxiety
  • drug exposure during pregnancy
  • anaemia
  • chest pain
40-49:
  • nausea
  • dyspnoea
  • chest pain
  • depression
  • pain
  • pyrexia
  • vomiting
  • fatigue
  • abdominal pain
  • anxiety
50-59:
  • depression
  • nausea
  • anxiety
  • pain
  • vomiting
  • pyrexia
  • asthenia
  • dyspnoea
  • fatigue
  • arthralgia
60+:
  • nausea
  • vomiting
  • dyspnoea
  • anxiety
  • weight decreased
  • fatigue
  • fall
  • diarrhoea
  • asthenia
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Reglan and Ranitidine?

Can you answer these questions?

More questions for: Reglan, Ranitidine

You may be interested in these reviews

More reviews for: Reglan, Ranitidine

On eHealthMe, Reglan (metoclopramide hydrochloride) is often used to treat nausea. Ranitidine (ranitidine) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.